Small Implantable 6 Month Sensor
The 6 month sensor is implanted inside the upper arm by a trained Eversense Inserter and is replaced twice a year. At less than ¾” long and less than ⅙” wide, the small sensor fits comfortably under the skin.
Manage your diabetes, not your CGM. Eversense E3 is the only 6 month CGM designed to fit your life, reduce device frustrations and give you more peace of mind over your self-management.
The difference is inside. See how Eversense E3 gives you 6 months of real-time, reliable glucose readings from a small sensor under the skin in your upper arm.
The 6 month sensor is implanted inside the upper arm by a trained Eversense Inserter and is replaced twice a year. At less than ¾” long and less than ⅙” wide, the small sensor fits comfortably under the skin.
Take naked showers again. An easy-on, easy-off smart transmitter can be removed when needed,* uses a gentle adhesive for daily use and provides distinct on-body vibe alerts when high or low.
Our mild, silicone-based adhesives are changed daily and are gentle on the skin with almost no skin reactions (1%).2
The Eversense app receives and displays your glucose data in simple charts and graphs to help you make informed decisions on the go. Compatible with Android™ or iOS® smartphone and Apple Watch®.
Simple Process, Continuous Support
A short, in-office procedure twice a year is all it takes for more peace of mind over your diabetes management. Get started in a few simple steps. Begin by taking a short quiz to see if you qualify.
Questions about Cost & Insurance?
When it comes to coverage, it helps to know you have options. We’ll help you navigate what assistance is available to fit your needs.
300+ million people have insurance that covers the Eversense E3 CGM System. We offer a free benefits investigation for those who pre-qualify.
Eversense gives you real-time glucose readings through a small sensor that’s placed just under the skin of your upper arm by a healthcare professional. The smart transmitter sits above the sensor, sending glucose data to your app. Want to learn more about the science behind Eversense? Check out our “How Eversense Works” video!
Eversense E3 is the only implantable sensor for long term wear - see how we compare!
If you’re on multiple daily doses of insulin and if you answer yes to any of the below questions, you may be a great candidate for Eversense!
1. Would you prefer only 2 sensor changes a year?
2. Do you have skin irritation from the adhesive of your current CGM?
3. Are you tired of false lows/false readings or gaps in data?
4. Would you like to have the freedom to remove your CGM transmitter without wasting the sensor?
5. Do your CGM alerts sometimes disrupt those around you?
Download our discussion guide and bring it to your next appointment and talk to your doctor about how Eversense may be a better fit for your diabetes management plan. We will work with you and your health care provider to manage your insurance claim.
Depending on your specific insurance plan, there could be differences in cost. We are happy to help you navigate getting more information about your insurance coverage. Just fill out the Pre-Qualification form, and we will be happy to contact you.
If you're on insulin, you might greatly benefit from Eversense. Whether you’re ready to get started now or just have additional questions about Eversense, an Ascensia Diabetes Care (Ascensia) representative can help. Fill in and submit the form below and we’ll be in touch via phone or text. We’ll also send you additional information about Eversense to help with your decision.
All fields marked with an asterisk (*) are required.
A Diabetes Therapy Associate will be in touch shortly, but if you want to reach out sooner, please call 1-945-221-9068.
To help expedite benefits verification, please have your doctor and insurance information handy.
We will attempt to reach you by phone first, and will send a text and email as well. The call may be displayed on your phone as "Eversense CGM". However, it will come from a number you are unfamiliar with, so be sure to check your voicemail box. The email from our representative will come from an @ascensia.com email address. If you haven’t received any email communications from our team within a few days, please check the spam folder in your email account.
Unfortunately, based on the insulin therapy regimen or insurance information you provided, you may not be eligible for Eversense E3 CGM. In order to qualify, you must be on multiple daily doses of insulin.
If your commercial insurance plan does not cover Eversense E3 CGM, our Eversense PASS™ program may help reduce your out-of-pocket cost for the product. .
If you have any questions, please reach out to 1-844-736-7348.
* There is no glucose data generated when the transmitter is removed
1. Garg, Satish K., et al. “Evaluation of accuracy and safety of the next-generation up to 180-day long-term implantable Eversense continuous glucose monitoring system: The promise study.” Diabetes Technology & Therapeutics, vol. 24, no. 2, 1 Feb. 2022, pp. 84–92, https://doi.org/10.1089/dia.2021.0182.
2. Deiss D., et al. (2020). Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry Study. Diabetes Technol & Ther, 22(1);48-52. DOI: 10.1089/dia.2019.0159.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more. For safety information click here.
Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0059